Epilepsy Trial, Recruiting (NCT04677751)

Epilepsy Trial, Recruiting NCT04677751 Sponsor: The University of Texas Health Science Center, Houston Condition: Epilepsy

Printed from Voxsanity (voxsanity.com.au) — NCT04677751 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Epilepsy

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

The person has already had the RNS system (a brain stimulation device) surgically implanted.
The person is able to attend and complete 12 weeks of acupuncture sessions.
The person is able to stay on the same medications without changes for 12 weeks.
The person is able to keep their RNS device settings unchanged for 12 weeks.
The person, or their caregiver, is able to understand and sign the consent and privacy forms required to participate.
The person, or their caregiver, is able to keep a diary tracking seizures throughout the study.

Who may not be able to join:

The person and their caregiver are unable to sign the required consent forms for the study.
The person has a bleeding disorder, has a pacemaker, or is pregnant.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 23 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Olga Rodziyevska, MS,PA-C, The University of Texas Health Science Center, Houston

Phone: (713) 500-5482

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT04677751

Sponsor: The University of Texas Health Science Center, Houston

Phase: Not Applicable

Status: Recruiting

Condition: Epilepsy

Trial contact: (713) 500-5482

More information: https://clinicaltrials.gov/study/NCT04677751

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

The person has already had the RNS system (a brain stimulation device) surgically implanted.
The person is able to attend and complete 12 weeks of acupuncture sessions.
The person is able to stay on the same medications without changes for 12 weeks.
The person is able to keep their RNS device settings unchanged for 12 weeks.
The person, or their caregiver, is able to understand and sign the consent and privacy forms required to participate.
The person, or their caregiver, is able to keep a diary tracking seizures throughout the study.

Who may not be able to join:

The person and their caregiver are unable to sign the required consent forms for the study.
The person has a bleeding disorder, has a pacemaker, or is pregnant.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 23 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

The University of Texas Health Science Center, Houston

Registry

ClinicalTrials.gov

Start date

1 April 2021

Est. completion

1 December 2025

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Percent change in number of disabling clinical seizures; Changes in seizure severity

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov